Highlights•The use of Cannabis as a complementary and alternative medicine in
inflammatory bowel disease has increased due to the evolving policies regarding its …

Marijuana derived from the plant Cannabis sativa has been used for the treatment of many
gastrointestinal (GI) disorders, including anorexia, emesis, abdominal pain, diarrhea, and …

The endocannabinoid system (ECS) consists of cannabinoid receptors, endogenous ligands
and the biosynthetic and metabolic enzymes for their formation and degradation. Within the …

Cannabis sativa and its extracts have been used for centuries, both medicinally and
recreationally. There is accumulating evidence that exogenous cannabis and related …

Cannabinoid receptors of type 1 and 2 (CB1 and CB2), endogenous ligands that activate
them (endocannabinoids), and mechanisms for endocannabinoid biosynthesis and …

Many beneficial effects of herbal and synthetic cannabinoids on gut motility and
inflammation have been demonstrated, suggesting a vast potential for these compounds in …

Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric
infections and inflammatory conditions to disorders of motility, emesis and abdominal pain …

For many centuries, cannabis (marijuana) has been used for both recreational and
medicinal purposes. Currently, there are about 192 million cannabis users worldwide …

Background Inflammatory bowel disease (IBD) is a lifelong disease of the gastrointestinal
tract whose annual incidence and prevalence is on the rise. Current immunosuppressive …

Background: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal
disorders. Its pathophysiology is diverse and variable, involving disturbed gut–brain …